m.v.i.-12 retinol ergocalciferol .alpha.-tocopherol acetate dl- ascorbic acid niacinamide riboflavin 5-phosphate sodium thiamine
hospira worldwide, inc. - retinol (unii: g2sh0xkk91) (retinol - unii:g2sh0xkk91) - retinol 1 mg in 5 ml
m.v.i. adult retinol ergocalciferol .alpha.-tocopherol acetate dl- phytonadione ascorbic acid niacinamide riboflavin 5-phosphate
hospira worldwide, inc. - retinol (unii: g2sh0xkk91) (retinol - unii:g2sh0xkk91) - retinol 1 mg in 5 ml
m.v.i. adult- retinol, ergocalciferol, .alpha.-tocopherol acetate, dl-, phytonadione, ascorbic acid, niacinamide, riboflavin 5-p
hospira, inc. - retinol (unii: g2sh0xkk91) (retinol - unii:g2sh0xkk91), ergocalciferol (unii: vs041h42xc) (ergocalciferol - unii:vs041h42xc), .alpha.-tocopherol acetate, dl- (unii: wr1wpi7ew8) (.alpha.-tocopherol, dl- - unii:7qwa1rio01), phytonadione (unii: a034se7857) (phytonadione - unii:a034se7857), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), riboflavin 5'-phosphate sodium (unii: 20rd1dzh99) (flavin mononucleotide - unii:7n464 - retinol 1 mg in 5 ml - m.v.i. adult™ is a combination of vitamins indicated for the prevention of vitamin deficiency in adults and pediatric patients aged 11 years and above receiving parenteral nutrition. the physician should not await the development of clinical signs of vitamin deficiency before initiating vitamin therapy. m.v.i. adult is contraindicated in patients who have: risk summary administration of the approved recommended dose of m.v.i. adult in parenteral nutrition is not expected to cause major birth defects, miscarriage, or adverse maternal or fetal outcomes. pregnant women should follow the u.s. recommended daily allowances for pregnancy because their vitamin requirements may exceed those of nonpregnant women. deficiency of essential vitamins may result in adverse pregnancy outcomes (see clinical considerations) . animal reproduction studies have not been conducted with m.v.i. adult administered by intravenous infusion. the estimated background risk of major birth defects and miscarriage for the indicated population
retinol acetate
marbiopharm jsc - retinol acetate - capsules - 33000iu
retinol
altayvitamini cjsc - retinol palmitate - capsules - 100000iu
retinol acetate solution oily for oral and external use
marbiopharm jsc - retinol (retinol acetate) - solution oily for oral and external use - 34,4mg/ml
retinol acetate capsules
marbiopharm jsc - retinol - capsules - 33000iu
retinol 4,500unit / colecalciferol 450unit capsules
tor generics ltd - retinol palmitate; colecalciferol - oral capsule - 4500unit ; 450unit
retinol 4,500unit / colecalciferol 450unit capsules
alliance healthcare (distribution) ltd - retinol palmitate; colecalciferol - oral capsule - 4500unit ; 450unit
retinol 4,500unit / colecalciferol 450unit capsules
a a h pharmaceuticals ltd - retinol palmitate; colecalciferol - oral capsule - 4500unit ; 450unit